ReviewNeuropsychiatric disease and treatment2026
Functional Disability Among People with Schizophrenia in East Africa: A Systematic Review with Evidence Predominantly from Ethiopia.
Review in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Schizophrenia causes substantial impairment in social, occupational, family, and everyday functioning. East African evidence is dispersed across disability scales, quality-of-life measures, employment outcomes, longitudinal studies, rehabilitation trials, and qualitative research. This review synthesized the magnitude, domains, correlates, measurement approaches, and rehabilitation evidence for functional disability among people with schizophrenia in East Africa. Methods: We conducted a PRISMA 2020 systematic review of studies involving people with schizophrenia in eight East African countries. Outcomes included disability, social and occupational functioning, activities of daily living, participation, functional recovery, and quality of life. We extracted study characteristics, outcomes, correlates, intervention findings, and qualitative themes, and assessed methodological quality using design-specific Joanna Briggs Institute checklists. Results: Fifteen publications from 2005 to 2025 were included; 14 (93.3%) were from Ethiopia and one (6.7%) from Rwanda, with no eligible publications identified from the other six prespecified East African countries. Cross-sectional studies predominated. Measures included WHOQOL-BREF, 36-item and 12-item WHODAS 2.0, SF-36, SOFAS, employment status, and qualitative approaches. Six publications had low risk-of-bias concern, eight had moderate concern, and one had high concern for causal or effect inference. Direct WHODAS evidence showed substantial disability, while longitudinal studies demonstrated persistent social and physical impairment. Negative symptoms, joblessness, prolonged untreated illness, substance use, weak social support, medication-related problems, and socioeconomic disadvantage were recurrent correlates. Community-based rehabilitation reduced disability in the cluster-randomized RISE trial. The available regional evidence is therefore heavily concentrated in Ethiopia. Conclusion: Functional impairment is multidimensional and extends beyond symptoms to work, social participation, daily activities, and quality of life. Integrated care should combine symptom management with rehabilitation, livelihood support, social inclusion, adherence support, and early treatment. Because the evidence is geographically concentrated in Ethiopia and uses heterogeneous measures, regional generalization should be cautious. Harmonized functional-outcome measurement and prospective multicountry research across East Africa are priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.